Chapter 1 Nanopharmaceuticals Market Overview
1.1 Nanopharmaceuticals Definition
1.2 Global Nanopharmaceuticals Market Size Status and Outlook (2016-2030)
1.3 Global Nanopharmaceuticals Market Size Comparison by Region (2016-2030)
1.4 Global Nanopharmaceuticals Market Size Comparison by Type (2016-2030)
1.5 Global Nanopharmaceuticals Market Size Comparison by Application (2016-2030)
1.6 Global Nanopharmaceuticals Market Size Comparison by Sales Channel (2016-2030)
1.7 Nanopharmaceuticals Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Nanopharmaceuticals Market Segment Analysis by Player
2.1 Global Nanopharmaceuticals Sales and Market Share by Player (2019-2021)
2.2 Global Nanopharmaceuticals Revenue and Market Share by Player (2019-2021)
2.3 Global Nanopharmaceuticals Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Nanopharmaceuticals Market Segment Analysis by Type
3.1 Global Nanopharmaceuticals Market by Type
3.1.1 Liposomes
3.1.2 Polymeric Micelles
3.1.3 Solid Lipid Nanoparticles
3.1.4 Microemulsion and Nnanoemulsion
3.1.5 Nanosuspension
3.2 Global Nanopharmaceuticals Sales and Market Share by Type (2016-2021)
3.3 Global Nanopharmaceuticals Revenue and Market Share by Type (2016-2021)
3.4 Global Nanopharmaceuticals Average Price by Type (2016-2021)
3.5 Leading Players of Nanopharmaceuticals by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Nanopharmaceuticals Market Segment Analysis by Application
4.1 Global Nanopharmaceuticals Market by Application
4.1.1 Cancer and Tumor
4.1.2 Autoimmune Disorders
4.1.3 Inflammation
4.1.4 Others
4.2 Global Nanopharmaceuticals Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Nanopharmaceuticals by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Nanopharmaceuticals Market Segment Analysis by Sales Channel
5.1 Global Nanopharmaceuticals Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Nanopharmaceuticals Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Nanopharmaceuticals by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Nanopharmaceuticals Market Segment Analysis by Region
6.1 Global Nanopharmaceuticals Market Size and CAGR by Region (2016-2030)
6.2 Global Nanopharmaceuticals Sales and Market Share by Region (2016-2021)
6.3 Global Nanopharmaceuticals Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Nanopharmaceuticals Market Share by Type
6.4.3 North America Nanopharmaceuticals Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Nanopharmaceuticals Market Share by Type
6.5.3 Europe Nanopharmaceuticals Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Nanopharmaceuticals Market Share by Type
6.6.3 Asia-Pacific Nanopharmaceuticals Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Nanopharmaceuticals Market Share by Type
6.7.3 South America Nanopharmaceuticals Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Nanopharmaceuticals Market Share by Type
6.8.3 Middle East & Africa Nanopharmaceuticals Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Nanopharmaceuticals Players
7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Pfizer
7.3 Novartis
7.4 Abbott
7.5 GlaxoSmithKline
7.6 Roche
7.7 Sanofi
7.8 Eli Lilly
7.9 Astrazeneca
7.10 Johnson & Johnson
7.11 Celgene
7.12 Novavax
7.13 Stryker
7.14 Gilead Sciences
7.15 OSI Pharmaceuticals
7.16 Kadmon Pharmaceuticals
7.17 Samyang Biopharm
7.18 Mitsubishi Pharma
7.19 Kaken Pharmaceutical
7.20 Selecta Biosciences
7.21 Par Pharmaceutical
7.22 Cerulean Pharma
7.23 Navidea Biopharmaceuticals
7.24 Lummy
Chapter 8 Upstream and Downstream Analysis of Nanopharmaceuticals
8.1 Industrial Chain of Nanopharmaceuticals
8.2 Upstream of Nanopharmaceuticals
8.3 Downstream of Nanopharmaceuticals
Chapter 9 Development Trend of Nanopharmaceuticals (2022-2030)
9.1 Global Nanopharmaceuticals Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Nanopharmaceuticals Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Nanopharmaceuticals Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Nanopharmaceuticals Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Nanopharmaceuticals Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
